Despite remaining positive on the £1.3bn Syncona investment trust, experts are questioning its place on the interactive investor's ethical buy list, the ii ACE 40, following the platform’s decision to place it under formal review.
In the year to 11 August the trust has lost 16.1%, while the Association of Investment Companies (AIC) Biotechnology and Healthcare sector has returned 8%. The premium has also narrowed significantly from around 30% at the end of January to 10%, according to FE fundinfo. The interactive investor list is designed to offer "the whole spectrum" of investments and aims to "be suitable for all investors". The list is continuously monitored for performance and other major change, according to the firm. With regards to Syncona, Dzmitry Lipski, head of funds research at interactive inve...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
